Nalaganje...

Prefusion F-based polyanhydride nanovaccine induces both humoral and cell-mediated immunity resulting in long-lasting protection against respiratory syncytial virus

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection in both young children and in older adults. Despite the morbidity, mortality, and high economic burden caused by RSV worldwide, no licensed vaccine is currently available. We have developed a novel RSV vaccine...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Immunol
Main Authors: Stephens, Laura M., Ross, Kathleen A., Waldstein, Kody A., Legge, Kevin L., McLellan, Jason S., Narasimhan, Balaji, Varga, Steven M.
Format: Artigo
Jezik:Inglês
Izdano: 2021
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8062305/
https://ncbi.nlm.nih.gov/pubmed/33827894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.2100018
Oznake: Označite
Brez oznak, prvi označite!